Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-09 Sale |
2024-09-11 4:00 pm |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
20,000 | $9.5 | $190,000 | 101,957 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-22 Option Award |
2025-01-24 4:09 pm |
N/A 2035-01-21 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
140,000 | $4.37 | 140,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 4:02 pm |
N/A 2034-01-23 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
110,000 | $3.06 | 110,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:03 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-15 6:15 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
1,858 | $3.72 | 175,673 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-15 6:15 pm |
N/A 2029-02-12 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
1,858 | $0 | 175,673 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:10 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
3,717 | $3.72 | 175,673 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:10 pm |
N/A 2028-01-30 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
4,392 | $0 | 175,673 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:10 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
675 | $0.73 | 175,673 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:27 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2022-01-11 4:03 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
0 | $0 | 320,267 (Direct) |
View |
Ownership |
2020-11-13 5:52 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. See Remarks |
0 | $0 | 270,267 (Direct) |
View |